[Abstract Only] Randomized Trial: Overall Survival with a (CDK) 4/6 inhibitor plus Endocrine Therapy in Breast Cancer
19 Jun, 2019 | 07:48h | UTCOverall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: MONALEESA-7 Shows Overall Survival Benefit for Ribociclib/Endocrine Therapy – The ASCO Post (free)